Resverlogix: The Future of Drug Development
Resverlogix is a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses and providing value-bas …
Developing safe, epigenetic therapeutics for people suffering from chronic illnesses
Resverlogix is a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses and providing value-based health solutions to key partners.
The Company was founded in 2001 by Donald McCaffrey and Norman Wong. They're a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses. They provide novel science, clinical, and value-based health solutions to key stakeholders such as pharmaceutical, physician, and health payer groups.
For more information on Resverlogix Corp. (TSX: RVX) please click the investor request info button.
Latest Articles
Hot Companies
You might also like
.jpg)
ONGold Resources: Unlocking Canada’s Hidden Gold Potential
ONGold Resources is redefining mineral exploration with a fresh approach to unlocking gold in Canada’s most prolific mining belt. Their data-driven, modern exploration strategy aims to turn untapped geology into next-generation discovery.
